Abstract
OrthoLogic (formerly Chrysalis) is developing Chrysalin, a synthetic 23-amino acid peptide that mimics a portion of human thrombin. The compound is in phase II clinical trials for the potential treatment of diabetic foot ulcers and phase III trials for cartilage repair and bone fractures.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 264-272 |
| Number of pages | 9 |
| Journal | Current Opinion in Molecular Therapeutics |
| Volume | 7 |
| Issue number | 3 |
| State | Published - Jun 2005 |
| Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics
- Pharmacology
- Drug Discovery
- Genetics(clinical)